Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYRIAD: Volatile Anesthetics in CABG
NCT02105610Phase 4Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Apr 2014
- Primary completion
- Oct 2017
- Modality
- Allosteric Modulators
- Countries
- 13
01
Overview
Phase 4, randomised, single-blind trial of desflurane, isoflurane and sevoflurane in coronary artery disease (CAD) (2 arms), sponsored by Vita-Salute San Raffaele University. Primary endpoint: Mortality from any cause at 1 year. Started Apr 2014; status: completed.
02
Drugs
desfluraneisofluranesevoflurane
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02105610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105610.